The Effects of Vitamin C on Cancer: A Cellular and Epidemiological Perspective by McLaughlin, Amy C
 Running head: THE EFFECTS OF VITAMIN C 1 
 
 
 
 
 
 
 
The Effects of Vitamin C on Cancer: 
A Cellular and Epidemiological Perspective 
 
 
 
 
 
 
 
 
 
 
 
Amy C. McLaughlin 
 
 
 
 
 
 
 
 
 
 
 
 
A Senior Thesis submitted in partial fulfillment 
of the requirements for graduation 
in the Honors Program 
Liberty University 
Spring 2013 
 
 
 
2 
THE EFFECTS OF VITAMIN C 
 
 
Acceptance of Senior Honors Thesis 
 
This Senior Honors Thesis is accepted in partial 
fulfillment of the requirements for graduation from the 
Honors Program of Liberty University. 
 
 
 
_____________________________________ 
Jeffrey L. Lennon, Ph.D. 
Thesis Chair 
 
 
 
 
 
______________________________________ 
David Titcomb, D.P.T. 
Committee Member 
 
 
 
 
______________________________________ 
Stephen J. Bell, M.A. 
Committee Member 
 
 
 
 
____________________________________ 
James H. Nutter, D.A. 
Honors Director 
 
 
 
 
_____________________________________ 
Date 
 
 
3 
THE EFFECTS OF VITAMIN C 
 
Abstract 
While vitamin C has been proven to benefit the immune system during acute infections, there are 
now many studies to support the findings that vitamin C may also contribute to more effective 
chemotherapy and lessened damage on the body as a result of chemotherapy. This thesis 
investigates the impact of vitamin C on many components of cancer such as C-reactive protein, 
interleukins, reactive oxygen species, and many types of antioxidants and examines vitamin C’s 
ability to inhibit or promote these agents’ functions in the body. In addition, this thesis evaluates 
the ability of vitamin C to keep tumor cells from developing, enhance the antioxidant abilities of 
other cellular components including vitamin E, lessen the carcinogenic environment produced by 
chronic inflammation, and diminish the effects of chemotherapy. This thesis concludes by 
comparing various methods of vitamin C administration and their varied levels of effectiveness 
in cancer treatment.  
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The Effects of Vitamin C on Cancer: A Cellular and Epidemiological Perspective 
 For the past four decades, dietitians and physicians have been promoting the intake of 
vitamin C to fight rhinoviruses and influenza, assist in nutrient digestion, and maintain stability 
in bone and connective tissue (Morgan, 2012; National Center for Biotechnology Information, 
2012). As an antioxidant, vitamin C can impede the spread of many foreign agents in the body. 
Because of the effectiveness of vitamin C on many physical processes, especially those having to 
do with illness, researchers have begun to wonder what other diseases vitamin C could be used to 
treat. Recently, researchers have devoted a great deal of time to studying the effects of vitamin C 
on cancer—its effects on cancer cells, natural body cells, and its impact on chemotherapy 
treatment. 
 The purpose of this thesis is to determine whether vitamin C is effective in impeding 
cancer growth and lessening the negative effects of chemotherapy on the body. This will be 
determined by examining several epidemiological studies on cancer and the effect of vitamin C 
on the malignant and natural cells on the subjects in each study. Viewing the processes of 
vitamin C from a cellular level will provide detailed information on its relationship to cancer, 
chemotherapy, and natural body cells. 
Definition of Terms 
For the purpose of this study, some terms need to be defined. Ascorbic acid, the chemical 
name for vitamin C, contains the chemical structure C6H8O6 (Hendrickson, 2011). Ascorbate, on 
the other hand, contains the chemical formula C6H7O6.  Because the two molecules are so close 
in structure, they are often used interchangeably, which will be the case in this thesis as well 
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(Hendrickson, 2011). When oxidation is mentioned in this thesis, it refers to the removal of one 
of a cell’s electrons as it is placed on another cell (Suhail et al., 2012). 
In regards to inflammation, four terms need to be defined. Any foreign substance that 
triggers an immune response is known as an antigen (Merriam Webster Dictionary, 2013). 
Cytokines are non-antibody proteins that help to produce an immune reaction in response to their 
interaction with certain antigens (The American Heritage Medical Dictionary, 2007). 
Chemokines are a type of cytokine that trigger the actions of lymphocytes, and interleukins are 
another type of cytokine that control the actions of T-cells (The American Heritage Medical 
Dictionary, 2007).  
Vitamin C as an Antioxidant 
 Vitamin C is an antioxidant, which means that it can “lose a hydrogen atom and…form a 
relatively stable ascorbate free radical” (Suhail et al., 2012, p. 25). In some situations, however, 
it can act as a prooxidant, where it accepts a hydrogen atom instead of giving one (Seifried, 
McDonald, Anderson, Greenwald, & Milner, 2003). Whether vitamin C acts as an antioxidant or 
a prooxidant depends on its oxidative state (2003).  
When other types of cells are oxidized, they often release free radicals such as reactive 
oxygen species (ROS) (Ratnam, Ankola, Bhardwaj, Sahana, & Ravi Kumar, 2006). While ROS 
are typically not harmful on their own, they can be converted into more destructive oxidative 
species and these, when they bind to a natural body cell, can cause the cell’s DNA to mutate 
(Ratnam et al., 2006). This mutation process causes the cell’s structure to be damaged and can 
result in neoplastic transformation (Lee, Lee, Surh, & Lee, 2003), the process by which non-
cancerous natural body cells are converted into cancerous tumors (Mosby’s Medical Dictionary, 
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2009).  As an antioxidant, ascorbic acid can neutralize these free radicals and keep them from 
damaging natural cells (Kim et al., 2010; Ratnam et al., 2006). 
Two of the most abundant free radicals that cause this type of damage are oxidized 
versions of glutathione, a non-enzymatic peptide that typically acts as an antioxidant, and MDA, 
a type of lipid (Suhail et al., 2012). Because ascorbic acid can keep glutathione from becoming 
oxidized, it can keep the levels of non-oxidized glutathione high in the body, thereby reducing 
the damage caused by this free radical in its oxidative state. In fact, in Suhail et al.’s study they 
measured the activity of several different enzymes that scavenge, or neutralize, free radicals. 
After treating twenty breast cancer patients with both chemotherapy and vitamin C and another 
twenty with chemotherapy alone, Suhail et al. found that individuals who also supplemented 
with vitamin C treatment had higher levels of free radical enzymes like superoxide dismutase 
(SOD), catalase, glutathione-S-transferase, and glutathione reductase, than those who took 
chemotherapy alone (2012). Lamson et al. found similar results in their study: “A number of 
human cancers demonstrate low levels of intracellular antioxidant enzymes (catalase, glutathione 
peroxidase) and smaller antioxidant molecules (glutathione, vitamin E, vitamin C, and vitamin 
A)” (2010, p.245). 
 According to Singh & Bhat, “The SODs represent the major cellular defense system 
against superoxide radicals” (2012, p. 2601). In their study, Singh & Bhat determined the levels 
of protein expression of SOD1, SOD2, and SOD3. They performed this study by administering 
vitamin C, vitamin E, BHA, or a combination of the three to female rats with breast cancer. 
While after 240 days of treatment the levels of SOD3 protein expression had increased in the rats 
treated with vitamin C and BHA, it had decreased in the rats taking vitamin E. They concluded 
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that “antioxidants vitamin C (Vit C) and BHA can prevent E2-induced breast cancer in female 
ACI rats” (p. 2601).  
 Another component linked to the production of SOD3 is nuclear factor erythroid 2-
related factor 2 (NRF2), which according to Singh & Bhat (2012), is “the master regulator of the 
antioxidant response” and can assist in the production of SOD3 (p. 2601). In addition to 
measuring the amounts of SOD3 present after the end of the treatment period, Singh & Bhat also 
measured the amount of NRF2 to determine if vitamin C had an influence on the amount of 
NRF2 produced. While NRF2 protein expression decreased with vitamin E treatment, it 
significantly increased with vitamin C and BHA treatment.  
 Although SOD3 has not been as well researched as SOD1 and SOD2, recent studies 
indicate that it is most likely linked to preventing DNA damage (Singh & Bhat, 2012). Vitamin 
C’s ability to increase the levels of SOD3 and NRF2 (which triggers SOD3) in rats with cancer 
could produce the same effects in epidemiological trials. Based on this study, vitamin C could be 
beneficial in increasing the rates of SODs in the body, and indirectly increasing the ability of the 
body to fight tumor cells (Singh & Bhat, 2012). 
 Lipid peroxidation, the process by which electrons are removed from cell membrane 
lipids (Northwestern University), is another oxidative process that can cause the development of 
cancer cells (Mohan & Priya, 2009). According to Mohan & Priya (2009),“lipid peroxidation 
mediated by free radicals is considered to be the major mechanism of cell membrane destruction 
and cell damage” (p. 1).  In their study, Mohan & Priya (2009) tested thirty-eight patients with 
ovarian cancer and compared them to thirty-eight controls of similar age. Compared to the 
controls, the participants with ovarian cancer had lower levels of antioxidants such as ascorbic 
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acid, GSH, catalase, and vitamin E, and higher levels of lipid peroxidation. These increased 
levels of lipid peroxidation indicate that more oxidative stress was present in the cells of subjects 
with cancer. In Suhail et al.’s study (2012), the levels of lipid peroxidation were higher in the 
forty breast cancer patients who did not receive treatment than in the forty controls. In addition, 
levels of lipid peroxidation (MDA) were lower in those who received vitamin C and E 
supplementation than those who received just chemotherapy. Based on these findings, other 
researchers have determined that consistently high doses of vitamin C could allow the inhibition 
of lipid peroxidation in cancer patients (Lee et al., 2003).  
Vitamin C’s effectiveness as an antioxidant is also demonstrated in another study, in 
which dietary and supplemental intakes of vitamins A, C, and E of 288 healthy controls were 
compared to 144 women of the same age with cervical cancer. Based on a statistical analysis of 
the study, “the subjects in the highest quartiles of dietary vitamin A, β-carotene, and vitamin C 
intakes had statistically significantly lower cervical cancer risk than those in the lowest 
quartiles’’ (Kim et al., 2010, p. 183). Other studies also support the idea that vitamin C is 
inversely associated with lowered cancer risk (Kim et al., 2010).  
Dietary Effectiveness of Vitamin C 
In addition to vitamin C supplementation, a study measuring the amount of vitamin C in 
the Italian’s natural diet indicates that 130 or more milligrams of vitamin C can also be effective 
when consumed as part of a daily diet (Bidoli et al., 2009). Evaluating the effectiveness of 
dietary vitamin C is important because the body can absorb a greater percentage of dietary 
vitamin C than it can from a supplement (University of Maryland Medical Center, 2011).  
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One study evaluating this data included 1294 men with prostate cancer and 1451 controls 
in various regions of Italy. Surveys of their diets were taken to determine how much vitamin C 
and E they consumed regularly. There was a significant relationship between high intake of 
vitamin E and lower prostate cancer risk, but only a slight relationship between the same intake 
of vitamin C and lower cancer risk. However, since the study took place in Italy, most of the 
participants were consuming a Mediterranean diet high in vitamin E, but not in vitamin C. If they 
had been eating a diet which incorporated higher levels of vitamin C, the correlation of vitamin 
C to lowered cancer risk would likely have been stronger (Bidoli et al., 2009). Another study 
investigating this topic found similar results. After measuring the levels of vitamin C and zinc in 
155 Indians suffering from laryngeal cancer, Kapil et al. concluded that vitamin A had the 
strongest impact on lowering laryngeal cancer risk but that “the people with the highest level of 
vitamin C intake were at a low risk for laryngeal cancer” as well (Kapil et al., 2003, p.69).  
Another example of dietary vitamin C impeding cancer growth is in a study of Iraqi 
citizens and the incidence of esophageal cancer. The researchers compared the amount of 
vitamins that the participants consumed daily in their diets with their risk of developing 
esophageal cancer (Malekshah et al., 2010). At the end of the study, Malekshah et al. determined 
that the region in Iraq which featured the highest number of cases of esophageal cancer also 
consumed the lowest amount of vitamins in their diets than all the other regions measured. In 
addition, the women in the study displayed more cases of esophageal cancer than men, and the 
percentage of vitamin C intake below RDA was 68% among the women compared to only 55% 
among the men (Malekshah et al., 2010). 
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The Effect of Vitamin C on Tumor Cells 
Vitamin C’s Interaction with p53 
 Many studies have been performed on ascorbate, a component of vitamin C, and its effect 
on tumor cells (Kim et al., 2012). Besides directly damaging the chemical make-up of tumor 
cells, vitamin C can also assist other chemicals in this process and prevent the damage to natural 
cells that occurs during chemotherapy In fact, Kim et al. (2012) found that “pharmacological [.5 
mM and higher] concentrations of ascorbate selectively kill cancer cells but not normal cells, a 
characteristic of an ideal cancer drug” (p. 1607).  
 A key element in tumor cells is p53, a transcription factor that modulates stresses to 
DNA. It can thwart the growth of tumors, halt a tumor cell in the middle of its metabolic cycle, 
and cause tumor cells to die (Kim et al., 2012). In a recent study, the researchers tested levels of 
p53 on two types of tumor cells while adding the same amount of ascorbate to the two tumor 
cells. Next, they measured the levels of p53 in each tumor cell and compared them to the 
effectiveness of ascorbate in damaging each tumor cell. When this study was performed in vitro, 
the tumor cells that had higher levels of p53 responded better to the cytotoxicity caused by 
ascorbate than the cells with lower levels of p53. In both types of tumor cells, the results were 
similar. This experiment was repeated in vivo on live mice, with similar results: tumors that did 
not have p53 present increased in size three times as much as the tumor cells that had p53 present 
(Kim et al., 2012).   
 Based on these results, p53 has been shown to increase cellular oxidative stress, which 
helps to destroy cancer cells or at least to inhibit their growth, especially when combined with 
the oxidative properties of ascorbate. Ascorbate cytotoxicity seems to be more effective in cells 
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with higher levels of p53 because p53 is an agent that moderates oxidative stress. Because 
natural body cells have lower levels of p53 than tumor cells, ascorbate does not damage these 
cells as much (Kim et al, 2012). The reactivation of p53 seems to maintain the cytotoxicity of 
ascorbate more consistently in cancer treatments. The effectiveness of vitamin C in destroying 
tumor cells when combined with p53, and the relatively small damage that it causes to natural 
cells, makes it a viable area of therapy to be tested in the battle against tumor cells (Kim et al., 
2012).   
Vitamin C’s Interaction with Hydrogen Peroxide 
 Kim et al. continued their study by measuring the amount of hydrogen peroxide that 
ascorbate produces. Hydrogen peroxide, which can be made from the transformation of 
superoxide radicals (Singh & Bhat, 2012), has been reported to damage tumor cells’ DNA 
(Quillin, 2005). When ascorbate was added to cancer cells to determine if ascorbate increases the 
amount of hydrogen peroxide produced, the amount of hydrogen peroxide increased in one type 
of cancer cell, HCT116+/+, but not in the other, HCT116-/-. In general, hydrogen peroxide 
increased more in HCT116-/- cells that also had p53 than in those that did not (Singh & Bhat, 
2012). Similarly, in Beating Cancer with Nutrition, Quillin (2005) found that vitamin C produces 
a large amount of hydrogen peroxide. 
However, a concern of hydrogen peroxide is that it could also damage natural body cells, 
producing mutations that could lead to cancer (Lee, Lee, Surh, & Lee, 2003). Two cellular-level 
processes can keep this from happening. One is that, although vitamin C can trigger the 
production of greater amounts of hydrogen peroxide to attack cancer cells, it can also indirectly 
reduce the production of hydrogen peroxide through its interaction with free ferric iron.  
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According to Lee et al, free ferric iron triggers the production of hydrogen peroxide, 
which can quickly mutate cancer cells and cause them to become malignant. However, in their in 
vitro study of vitamin C and cancer, Lee et al. found that vitamin C controls levels of free ferric 
iron, therefore preventing it from producing hydrogen peroxide and causing mutations. Lee et al. 
conclude that “vitamin C was found to predominantly reduce oxidative damage in vivo even in 
the presence of iron” (Lee et al., 2003, p. 1075).  
 Secondly, the properties of hydrogen peroxide can prove useful in cancer treatments 
because natural cells neutralize hydrogen peroxide in a way that tumor cells cannot (Quillin, 
2005). In the body’s natural cells, the enzyme catalase interacts with excess hydrogen peroxide 
and neutralizes it, preventing cell damage (Quillin, 2005; Singh & Bhat, 2012). However, cancer 
cells do not contain catalase, so excess hydrogen peroxide goes uninhibited, causing more 
damage (Quillin, 2005). This process can also be repeated with peroxidase, another enzyme that 
extracts hydrogen peroxide from natural cells (Singh & Bhat, 2012).  
Vitamin C’s Interaction with Reactive Oxygen Species 
 In addition to its interaction with p53 and hydrogen peroxide, ascorbate can also activate 
reactive oxygen species (ROS) which can damage DNA and cause cell death, although the extent 
to which ROS is beneficial in causing tumor cell death has been difficulty to study (Mamede et 
al., 2011; National Cancer Institute). According to Inoue et al. (2009), the amount of ROS 
present in a cell is critical to its ability to cause apoptosis, or cell death. While some of the results 
varied, many of the results gathered in Inoue et al.’s study of ROS assistance in tumor cell death 
showed that proteins such as p21 and p53 were more effective in their destruction of tumor cells 
when coupled with ROS (2009). Because ascorbate as an antioxidant tends to increase the 
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effectiveness of p53, higher levels of ROS in the cell could also make ascorbate more effective. 
According to Mamede et al. (2011), when ascorbate was combined with ROS scavenging agent 
NAC, the cells responded more strongly to the ascorbate than they did with the ascorbate alone.
 Another study validating the influence of vitamin C on tumor damage was an in vivo 
study on rats completed by Velanganni & Balasundaram (2010). In their study, the researchers 
injected a group of rats with p-dimethylaminoazobenzene (DAB), which resulted in the 
development of hepatoma, or liver cancer, in the rats. For six months, the researchers 
administered vitamin E, L-ascorbic acid, and vitamin A to the variable group. When the effects 
of the vitamins on the two groups were measured, the liver size did not enlarge as greatly in the 
rats treated with vitamins as in the ones who were not treated with vitamins. In addition, the 
DNA and RNA multiplied less in the tumors of the vitamin-treated rats than in the rats not 
treated with vitamins: DNA increased by 4.2 milligrams and RNA by 7.22 milligrams in the 
untreated rats, but only by 1.8 and 4.32 milligrams respectively in the treated rats (Velanganni & 
Balasundaram, 2010).  
The Effect of Vitamin C on Inflammation 
 Inflammation can be a major factor in cancer development (Federico, Morgillo, Tuccillo, 
Ciardiello, & Loguercio, 2007). According to Mikirova, Casciari, Rogers, & Taylor (2012), 
inflammation not only affects the growth of tumors, but also facilitates “tumour proliferation, 
angiogenesis, metastasis, and resistance to therapy” (p. 189). This facilitation is due to increasing 
levels of free radicals involved in inflammation, and their ability to decrease immune function 
(Kim et al., 2010).  
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 Many types of cancer, including colon carcinoma and liver cancer, result from chronic 
inflammatory diseases (Aggarwal, Vijayalekshmi, & Sung, 2009; Federico et al., 2007). In the 
case of acute infections, vitamin C helps to produce inflammation so that the infection can be 
contained (Aggarwal et al., 2009). This occurs when vitamin C triggers more T-lymphocytes to 
be produced, which in turn causes more cytokines and immunoglobulins to be produced (Hartel, 
Strunk, Bucsky, & Schultz, 2004).  However, a different process occurs when inflammation is 
present long-term (Aggarwal et al., 2009).  
 In long-term diseases, inflammatory cells produce a large number of oxygen free radicals 
which stay in the body for a longer period of time than they would in a short-term illness 
(Madhuri, Vani, Syed, & Alshatwi, 2011). This process is a result of an antigen interacting with 
an inflammatory cell, causing reactive oxygen species to be released into the body (Madhuri et 
al., 2011). Because many studies now support the idea that reactive oxygen species aid in cancer 
cells development, the treatment of inflammation via vitamin C therapy could prove vital in 
inhibiting cancer cell growth (Madhuri et al., 2011). In instances of chronic inflammation, 
Vitamin C has been shown to impede the release of several types of cells involved in 
inflammation, including C-reactive proteins, interleukin-6, tumor necrosis factor-alpha (TNF-), 
and certain types of reactive oxygen species (Mikrova et al., 2012; Hartel et al., 2004; Federico 
et al., 2007). 
 According to Mikirova et al. (2012), a cell unit called C-reactive protein (CRP) 
accompanies inflammation. It is produced when high levels of the cytokine IL-6  are present, 
and can be used to identify how much of an infection is present. The authors indicate that “there 
are particularly strong negative correlations between CRP levels and cancer survival in a wide 
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variety of cancer types” (p. 190). Based on these findings, Mikirova et al. (2012) measured the 
amount of CRP before and after 45 patients were treated with intravenous vitamin C therapy. 
The patients had various types of cancer, including prostate cancer, breast cancer, pancreatic 
cancer, lung cancer, thyroid cancer, and B-cell lymphoma. Seventy-five percent of the patients 
experienced a reduction in the amount of CRP compared to their levels of CRP before beginning 
intravenous vitamin C therapy (IVC). In addition, half of the patients who had a high level of 
CRP before beginning treatment experienced a reduction in their level of CRP after the IVC.  
 In a study completed by Hartel, Strunk, Bucsky, & Schultz (2004), which measured how 
much the production of intracytoplasmic cytokine production was affected by vitamin C, the 
monocytes that produce interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-) were 
inhibited from producing these types of cytokines  after doses of vitamin C were administered 
(Hartel et al., 2004). Because TNF-, IFN-, IL-1, IL-6, and IL-8 are all cytokines that work 
together to create an immune response, without the assistance of each type of cytokine, the 
immune response is not as strong (Hartel et al., 2004). In addition, based on the findings of 
Mikirova et al. (2012), a decreased production of IL-6 would result in a decreased production of 
CRP, and therefore can benefit the cancer patient’s prognosis. 
 Two other cell units involved in the inflammation process are reactive oxygen 
intermediates (ROI) and reactive nitrogen intermediates (RNI) (Federico et al., 2007). These free 
radicals are two intermediate factors in the metabolic process which can damage a portion of 
cells either directly or indirectly. Normally ROI and RNI are reabsorbed during the metabolic 
process through the actions of antioxidants such as superoxide dismutase, catalase, glutathione 
peroxidase, and glutathione (GSH), which keep the body in homeostasis and therefore unaffected 
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by excess ROI and RNI free radicals. However, when this system of homeostasis gets out of 
balance and more ROI and RNI are being produced than are being absorbed, which results in 
oxidative and nitrosative stress. This stress can cause the apoptosis or regeneration of normal 
body cells as well as trigger mutations that lead to the development of tumor cells (Federico et 
al., 2007; Lee et al., 2003). Because ROI and RNI recruit additional inflammatory cells, such as 
cytokines, which have harmful effects on natural body cells, they can also indirectly contribute to 
further cell damage (Federico et al., 2007).  
 Similar to its effects on other reactive oxygen species, high doses of vitamin C have been 
shown to neutralize the oxidative effects of ROI and RNI in the body, inhibiting these free 
radicals’ ability to cause DNA damage (Lee et al., 2003). According to Kapil et al. (2004), 
“[vitamin C] may prevent cancer through its ability to scavenge and reduce nitrate, thereby 
reducing the substrate for the reaction with secondary amines to form nitrosamines” (p. 69). With 
its ability to scavenge free radicals and cause chemical reactions to occur among them, vitamin C 
can effectively inhibit processes that destroy natural DNA, of which RNI are a part (Lee et al., 
2003). 
 In addition to the damage that chronic inflammation can cause on natural body cells, the 
components of chronic inflammation can also provide an environment for tumor growth 
(Federico et al., 2007). One of the factors found to be active in most cancers is nuclear factor-kB 
(NFkB), which according to Aggarwal et al. is “a nuclear factor that binds to the enhancer region 
of the kB chain of immunoglobulin in B cells” (2009, p. 425). NFkB regulates process such as 
inflammation, angiogenesis, and metastasis, and in turn can be activated by factors that trigger 
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inflammation, such as carcinogens, hyperglycemia, and radiation. Cytokines such as TNF and 
IL-1 also activate NFkB (Aggarwal et al., 2009).  
 Although it is typically involved in the growth process of most cancers, NFkB could 
actually assist in protecting natural cells against cancer (Lee et al., 2003; Owuor & Kong, 2002). 
In small amounts, NFkB contributes to the detoxification of antioxidants, but can also contribute 
to cancer formation in larger amounts (Lee et al., 2003). In their study, Lee et al. postulated that 
if ascorbate could replace NFkB completely in this detoxification process, the damaging effects 
of high levels of NFkB would no longer be a concern (2003).  
Vitamin C and Chemotherapy 
Lessened Damage on Natural Cells’ DNA 
 In several instances, vitamin C has been shown to lessen the damage on natural cells 
while a cancer patient is undergoing chemotherapy. In a study completed by Madhuri et al. 
(2011), 80 patients with gastric cancer were treated with both chemotherapy and vitamin C 
treatment to determine if the number of changes to natural lymphocytic chromosomes was less in 
those who had taken vitamin C therapy and chemotherapy compared to those who had undergone 
chemotherapy alone. Patients who underwent vitamin C therapy as well as chemotherapy were 
found to have much smaller amounts of chromosomal aberrations than those who took 
chemotherapy alone. Antunes et al. produced similar results when they tested the number of 
chromosomal aberrations after chemotherapy with and without vitamin C: those who received 
vitamin C therapy in addition to chemotherapy had a lower number of chromosomal aberrations 
than those who did not (Madhuri et al., 2011). In another study which investigated a similar 
protocol with breast cancer patients, the researchers found that the patients who were 
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administered both vitamin C & E therapy (VCE) and chemotherapy had lower levels of DNA 
damage than those who were administered chemotherapy alone (Suhail et al., 2012). 
 In addition to chromosomal aberrations, 500 mg doses of vitamin C can also protect 
against the harmful effects of 8-oxoguanine, an oxidized form of DNA, on natural DNA. 8-
oxoguanine has been found to be mutagenic to natural cells’ DNA (Lee et al., 2003). In a study 
by Podmore et al. (1998), the researchers found that the cancer patients who took 500 milligrams 
of vitamin C daily experienced a decrease of 8-oxoguanine concentrations compared to those 
who were not taking vitamin C supplements (Lee et al., 2003). In another study results were 
similar: there was a negative correlation between vitamin C dosage and the level of 8-oxo-
deoxyguanosine, which can also be harmful to DNA (Lee et al., 2003).  
Lessened Side Effects of Chemotherapy 
 Besides preventing direct damage to the DNA caused by chemotherapy, vitamin C can 
also maintain antioxidant levels in the body after a chemotherapy treatment (Ratnam et al., 
2006). This could make vitamin C a better choice for chemotherapy treatment than cisplatin, 
which is currently one of the most effective chemotherapeutic agents used to treat cancerous 
tumors (Weijl et al., 2004). While it has many positive attributes including its ability to 
effectively attack cancer cells without many negative side effects, one of cisplatin’s side effects 
is the extent to which it decreases plasma concentrations of antioxidants in the body, a result that 
is almost non-existent when vitamin C is used (Ratnam et al., 2006).  
In the study performed by this group of researchers, Weijl et al. administered 
supplements of vitamins C and E with selenium to some patients, and placebos to others. The 
study consisted of 48 subjects who had cancers such as testicular cancer, osteosarcoma, 
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gastrointestinal cancer, melanoma, urogenital cancer, and head and neck cancer. Twenty-five of 
the study participants received the supplemental treatment while 23 received the placebo, and 
each group had an equal number of cancer types. When the groups reached the nadir day of cycle 
1, both groups’ plasma concentrations of antioxidants were lower than when they had begun. 
However, after the nadir day of cycle 1, the levels of antioxidants in patients taking supplements 
began to rise, while the levels in the placebo group did not (Weijl et al., 2004).  
A part of Weijl et al.’s (2004) study that fails to show correlation is the fact that after 
chemotherapy was terminated, the levels of antioxidants in the two groups were not statistically 
different. However, because 64% of the group taking the supplements failed to take their 
supplements consistently, these results could be skewed. The authors believed that if that group 
had been more consistent in taking their supplements, the results would have been found more 
significant. 
When the results of Weijl et al.’s (2004) study are combined with the information already 
known about the benefits of antioxidants on tumor damage and protection of natural cells, further 
benefits of vitamin C in cancer treatment can be seen. Because vitamin C can also stay in the 
body in small amounts and be replenished quickly during chemotherapy treatments, the body 
does not have to fight the cancer for long before new waves of antioxidants can assist in the 
cancer-fighting process once again. 
Madhuri et al. (2011) report another aspect in which vitamin C can curb the effects of 
chemotherapy on further cancer growth. In their study they measured vitamin C intake in cancer 
patients and the amount of chromosomal aberrations in those patients’ cells. While Madhuri et al. 
state that normally unstable chromosome order can be a principal cause of cancer cell formation, 
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both in the beginnings of cancer as well as in metastasis, the results of their study indicate that 
vitamin C may be effective in decreasing the number of chromosomal changes that occur in the 
cell. 
The Effectiveness of Vitamin C in Combination with Vitamin E 
While vitamin C has been shown to be effective on its own, a study by Kim et al. found 
that vitamin C can increase its effects by working in cohesion with vitamin E. According to Kim 
et al. (2010), “Vitamin C…has an important function in sparing vitamin E, which is a lipid 
soluble antioxidant’’ (p. 188). Because vitamin C spares vitamin E, it can help direct the activity 
and processes that this vitamin performs, which are often similar to the effects vitamin C could 
perform on its own (2010). Many studies claim that vitamin C working synergistically with 
vitamin E can produce more effective damage to tumor cells than can vitamin C alone (Greenlee 
et al., 2012; Kim et al., 2010; Weijl et al., 2004). 
In a study by Greenlee et al. (2012), the results of a synergism between vitamin C and 
vitamin E were supportive of this idea. In their study, Greenlee et al. evaluated 2264 women with 
breast cancer. Of the 2264 women, 81% received at least one form of antioxidant supplement, 
40% took vitamin C supplements, 48% took vitamin E supplements, and 70% used multivitamin 
supplements, which typically contained both vitamin E and vitamin C. Greenlee et al. found that 
the women who took vitamin C supplements in combination with vitamin E supplements tended 
to have lower rates of all-cause mortality and a lower risk of the breast cancer recurring than 
those who did not take vitamin C supplements. 
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Effective Doses of Vitamin C for Cancer Cell Cytotoxicity 
 In studies performed in vitro, in vivo, and in live population samples, vitamin C has been 
shown effective in inhibiting the growth of tumors and protecting the body’s own cells. In many 
of the studies the patients only experienced the effectiveness of vitamin C at a specific dosage 
(Hartel et al., 2004; Huang, Helzlsouer, & Appel, 2000; Kim et al., 2012; Lee et al., 2003). 
Because the effectiveness of vitamin C is just beginning to be demonstrated in cancer treatment, 
only a small percentage of all of the studies on this topic have been able to determine effective 
dosages. However, more studies have been performed monitoring the activity of vitamin C 
against harmful cytokines, damage to the DNA of natural cells, and modulation of transcription 
factors, in which researchers have been able to determine effective dosages (Hartel et al., 2004; 
Lee et al., 2003; Podmore et al., 1998).  
Some researchers claim that patients who take doses of 500 or more milligrams of 
vitamin C a day actually experience damage to their natural cells’ DNA (Lee et al., 2003). 
However, Huang et al. concluded that any damage that vitamin C could cause at a dose of 500 
milligrams a day would not be enough to cause neoplastic transformation (2000). In another 
study, vitamin C supplementation at the levels of 5000 milligrams a day was not enough to cause 
DNA damage or cancer formation (Lee et al., 2003). According to Hartel et al., who completed a 
study about vitamin C and its effects on the long-term inflammation process, a twenty milliMolar 
concentration of ascorbate kept IL-6 and TNF-  from being produced, while leaving other 
levels of interleukins unaffected (2004). While these studies have demonstrated specific doses at 
which vitamin C is effective in specific situations, Kim et al. (2012) indicate that it is hard to get 
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a high enough amount of ascorbate through oral dosing, but intravenous doses, since they are 
higher, can be effective in causing cancer cell death (National Institutes of Health, 2011).  
 Some case studies support the effectiveness of intravenous doses of vitamin in cancer 
treatment. For example, in a case study of a 49-year-old man with a bladder tumor, the man was 
treated with 30 grams of intravenous vitamin C for three months, two times a week. After three 
months, he continued to receive 30 grams of intravenous vitamin C once every 1-2 months for 
four years. Nine years after being diagnosed with the bladder tumor, this man was cancer-free 
and did not exhibit signs of relapse or metastasis; ordinarily, this type of tumor would have 
quickly metastasized into other parts of the body.  
Similarly, in another case study, a 66-year-old woman with lymphoma received 15 grams 
of vitamin C intravenously twice a week for nine months, and then received the same amount 
every 2-3 months for the next year. While she did receive radiation treatments in addition to 
vitamin C therapy, she denied chemotherapy for the whole treatment phase. Additional lymph 
growths initially appeared. However, two years later the growths had all been eliminated and the 
woman was cancer-free (Padayatty et al., 2006).  
 While specific dosage is important, combining vitamin C with other types of 
chemotherapeutic drugs can also make the vitamin C more effective. In their study measuring 
how p-53 affects the ability of vitamin C to damage tumor cells, Kim et al. (2012) concluded that 
although vitamin C could cause significant damage to tumor cells, “a single treatment of 
ascorbate was not enough for complete regression of the tumor size” (p. 1614). In fact, the 
authors suggested combining vitamin C therapy with another type of chemotherapeutic treatment 
so that the ascorbate could be more effective than it would be on its own (2012).  
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 Some studies do not support the effectiveness of vitamin C in treatment. In a study by 
Lee et al., the researchers claimed that a dose of 20 milligrams of vitamin C per day is not 
beneficial in chemoprevention because the vitamin C could actually trigger the growth of tumor 
cells. However, the authors came to this conclusion based on the results of an in vitro study. The 
results would likely have been different in vivo, because of the assistive actions of glutathione 
peroxidase and catalase in neutralizing excess free radicals and curbing cancer growth (Lee et al., 
2003). 
 Another limitation of using vitamin C for cancer treatment is the length of time that 
vitamin C stays in the person’s body. According to Ratnam et al. (2006), “approximately 73% of 
ascorbic acid is [naturally] removed from the body in less than 24 hours” (p. 98). In  patients 
with compromised kidney function, vitamin C cannot be reabsorbed effectively, and even in 
healthy patients, it is difficult to maintain vitamin C levels in an individual’s system orally, even 
if the dose is as high as 1000 milligrams (Ratnam et al., 2006). To compensate for this problem, 
Ratnam et al. explain that some forms of vitamin C have now been manufactured to be absorbed 
in a time-release manner. Also, many studies have indicated that intravenous doses can be 
effective, because of their quick absorption rates (National Institutes of Health, 2011).  
 While most researchers have found that high doses of vitamin C positively benefit the 
body, a few researchers have found that high doses of vitamin C could actually cause DNA 
damage in natural cells (Lee et al., 2003). However, the unique properties of vitamin C as a 
natural supplement show that it may be able to act differently upon natural cells than it does 
upon tumor cells. For example, although vitamin C triggers a cascade of reactions that allow 
hydrogen peroxide to damage tumor cells, natural cells have the enzyme catalase to protect them 
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from this type of damage (Quillin, 2005). Because artificial chemotherapy agents are not able to 
differentiate between natural and tumor cells, vitamin C may still be a better alternative to some 
of these artificial drugs. In addition, Madhuri et al. (2011) concluded that the patients who 
received vitamin C therapy experienced less damage to their lymphocytic DNA than those who 
did not. While more studies need to be performed that conclude the negative effects of vitamin C 
on natural cells to be insignificant, current studies such as those by Kim et al. (2012), Lee et al. 
(2003), Padayatty et al. (2006), and Ratnam et al. (2006) vitamin C as a worthwhile choice for 
supplemental treatment. 
Non-Supportive Arguments Regarding the Effectiveness of Vitamin C in Cancer 
Treatment 
 While many studies have been performed emphasizing the positive effects of vitamin C 
in cancer treatment, others indicate that this may not be the case. A study performed by Zhang et 
al. measured the amounts of supplements, including vitamin C supplements, taken among 
132,837 participants in China and compared them to these participants’ liver cancer risk. Instead 
of the inverse correlation between vitamin C supplementation and cancer risk found in many of 
the other studies, Zhang et al. (2012) found a positive correlation between those who took 
vitamin C supplements and those who had a high risk of liver cancer. However, out of those who 
took vitamin C and had a high risk of liver cancer, many had a family history of liver disease or 
were regular smokers.   
 Unfortunately, Zhang et al.’s (2012) study is not the only one to conclude non-supportive 
results for effectiveness of vitamin C in cancer treatment. A study by Kirsh et al. consisted of 
29,361 men who were evaluated based on their intake of vitamin supplements and whether they 
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developed prostate cancer during the eight-year monitoring process. Of the total participants, 
56% used a multivitamin or single vitamin supplement: 52% took vitamin E, 42% took beta-
carotene, and 51% took vitamin C. At the end of the eight-year study, the relationship between 
taking vitamin C supplements and development of prostate cancer was not significant. However, 
Kirsh et al. state that a wide variety of studies on the same topic show that there is at least a 
relationship between supplement intake and lowered cancer risk in some subgroups of the 
population. 
Conclusion 
 While 50 years ago hardly any research had been performed to determine the 
effectiveness of vitamin C on cancer treatment, there are many studies today that evaluate 
various aspects of vitamin C’s relationship with tumor cells and neoplastic processes. The results 
of several studies indicate that vitamin C can be effective in multiple levels of cancer treatment. 
As an antioxidant, vitamin C can keep harmful free radicals from damaging natural DNA and 
causing neoplastic transformation (Ratnam et al., 2010). Its synergistic relationship with free 
radical enzymes such as superoxide dismutase, catalase, glutathione-S-transferase, and 
glutathione reductase allow greater work to be accomplished than could be accomplished with a 
single antioxidant, and its synergistic relationship with vitamin E allows the spared vitamin E to 
exercise greater antioxidant abilities than it could without vitamin C (Suhail et al., 2012; Kim et 
al., 2010; Weijl et al., 2004; Greenlee et al., 2012).  
With regards to transcription factors, ascorbate could possibly replace NFkB in the 
process of detoxifying antioxidants to prevent tumor growth (Lee et al., 2003), and has been 
shown to elevate the levels of NRF2 in the body, which through a cascade process help to 
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neutralize harmful free radicals (Singh & Bhat, 2012). Vitamin C can protect natural cells from 
chromosomal damage (Madhuri et al., 2011) and help to destroy cancer cells by activating 
hydrogen peroxide (Quillin, 2005). 
 Not all studies on vitamin C have yielded positive results. However, even studies like 
Zhang et al.’s and Kirsh et al.’s indicate limitations in their studies that may have kept the 
relationship between vitamin C and lowered cancer risk from being stronger. While the effect of 
vitamin C is not definitive, many studies support the view that vitamin C can be beneficial in 
cancer treatment. One of the most important findings in these studies is that vitamin C can cause 
damage to tumor cells without significantly harming natural cells (Quillin, 2005).  
By compiling the results of all of these studies and performing more research to 
determine vitamin C’s effectiveness as a chemotherapeutic agent, researchers could begin to 
determine stronger theories that would allow them to effectively recommend vitamin C as part of 
cancer therapy. Based on these results, oncologists could begin to prescribe vitamin C therapy as 
a primary form of treatment. While the extent to which vitamin C can affect tumors and the 
dosage of vitamin C most useful to cancer treatment has yet to be precisely determined, the 
strong evidence of vitamin C’s benefits, combined with its abilities to keep natural cells from 
harm, makes vitamin C a valuable supplement for cancer treatment.  
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